Ian Shakil - 24 May 2023 Form 4 Insider Report for Augmedix, Inc.

Signature
/s/ Todd Holvick, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
24 May 2023
Net transactions value
$0
Form type
4
Filing time
25 May 2023, 21:20:21 UTC
Previous filing
22 Feb 2023
Next filing
27 Feb 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Employee Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 24 May 2023 Common Stock 50,000 $3.84 Direct F1
transaction AUGX Employee Stock Option (right to buy) Award $0 +150,000 $0.000000 150,000 24 May 2023 Common Stock 150,000 $3.84 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. The option will vest monthly in equal increments over one (1) year starting on May 17, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F2 The option is granted under the Issuer's 2020 Equity Incentive Plan. Twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of May 17, 2023 and the remaining shares subject to the Option shall vest subsequently in thirty-six (36) equal monthly increments thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date.